Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hyperlipoproteinemias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    August 2019
  1. SKULAS-RAY AC, Wilson PWF, Harris WS, Brinton EA, et al
    Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Circulation. 2019 Aug 19:CIR0000000000000709. doi: 10.1161/CIR.0000000000000709.
    PubMed     Text format     Abstract available


    June 2019
  2. AHMAD Z, Banerjee P, Hamon S, Chan KC, et al
    Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.
    Circulation. 2019 Jun 27. doi: 10.1161/CIRCULATIONAHA.118.039107.
    PubMed     Text format     Abstract available


    July 2018
  3. GISTERA A, Klement ML, Polyzos KA, Mailer RK, et al
    LDL-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice.
    Circulation. 2018 Jul 11. pii: CIRCULATIONAHA.118.034076.
    PubMed     Text format     Abstract available


    May 2018
  4. XIANG R, Fan LL, Huang H, Chen YQ, et al
    Increased RTN3 Leads to Obesity and Hypertriglyceridemia by Interacting with HSPA5.
    Circulation. 2018 May 1. pii: CIRCULATIONAHA.117.030718.
    PubMed     Text format     Abstract available


    March 2018
  5. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    PubMed     Text format     Abstract available


  6. BUCHOLZ EM, Rodday AM, Kolor K, Khoury MJ, et al
    Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
    Circulation. 2018 Mar 26. pii: CIRCULATIONAHA.117.032321.
    PubMed     Text format     Abstract available


  7. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed     Text format    


    February 2018
  8. BALDER JW, Rimbert A, Zhang X, Viel M, et al
    Genetics, Lifestyle, and Low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women.
    Circulation. 2018;137:820-831.
    PubMed     Text format     Abstract available


  9. KUSTERS DM, Braamskamp MJAM, Langslet G, McCrindle BW, et al
    Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Ros
    Circulation. 2018;137:641-642.
    PubMed     Text format    


  10. KOH KK
    Letter by Koh Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
    Circulation. 2018;137:639-640.
    PubMed     Text format    


    December 2017
  11. HESS GP, Natarajan P, Faridi KF, Fievitz A, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.
    Circulation. 2017;136:2210-2219.
    PubMed     Text format     Abstract available


    November 2017
  12. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1984.
    PubMed     Text format    


  13. NATALE F, Di Maio M, Calabro P
    Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1982-1983.
    PubMed     Text format    


    September 2017
  14. VALLEJO-VAZ AJ, Robertson M, Catapano AL, Watts GF, et al
    LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.027966.
    PubMed     Text format     Abstract available


    August 2017
  15. DROUIN-CHARTIER JP, Tremblay AJ, Bergeron J, Lamarche B, et al
    The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2017;136:880-882.
    PubMed     Text format    


  16. TONTONOZ P, Wu X, Jones M, Zhang Z, et al
    Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia.
    Circulation. 2017;136:776-778.
    PubMed     Text format    


    July 2017
  17. BLOM DJ, Averna MR, Meagher EA, du Toit Theron H, et al
    Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2017;136:332-335.
    PubMed     Text format    


  18. LERMAN JB, Joshi AA, Chaturvedi A, Aberra TM, et al
    Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.
    Circulation. 2017;136:263-276.
    PubMed     Text format     Abstract available


    June 2017
  19. BRAAMSKAMP MJAM, Langslet G, McCrindle BW, Cassiman DM, et al
    Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study.
    Circulation. 2017 Jun 7. pii: CIRCULATIONAHA.116.025158.
    PubMed     Text format     Abstract available


    March 2017
  20. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
    Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
    Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
    PubMed     Text format     Abstract available


    November 2016
  21. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available


  22. DE FERRANTI S, Sheldrick RC, Wong JB
    Response by de Ferranti et al to Letter Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e395-e396.
    PubMed     Text format    


  23. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Letter by Perez de Isla et al Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e393-e394.
    PubMed     Text format    


    October 2016
  24. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


    July 2016
  25. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Text format     Abstract available


  26. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: